Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Endovascular Management of Atherosclerotic Renal Artery Stenosis: Post-Cardiovascular Outcomes in Renal Atherosclerotic Lesions Era Winner or False Alarm?

Karanikola E, Karaolanis G, Galyfos G, Barbaressos E, Palla V, Filis K.

Vasc Specialist Int. 2017 Mar;33(1):1-15. doi: 10.5758/vsi.2017.33.1.1. Epub 2017 Mar 31. Review.

2.

Approach to atherosclerotic renovascular disease: 2016.

Daloul R, Morrison AR.

Clin Kidney J. 2016 Oct;9(5):713-21. doi: 10.1093/ckj/sfw079. Epub 2016 Sep 16.

3.

Mortality and Renal Replacement Therapy after Renal Artery Stent Placement for Atherosclerotic Renovascular Disease.

Misra S, Khosla A, Allred J, Harmsen WS, Textor SC, McKusick MA.

J Vasc Interv Radiol. 2016 Aug;27(8):1215-24. doi: 10.1016/j.jvir.2016.05.001. Epub 2016 Jun 11.

4.

Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.

Tuttle KR, Dworkin LD, Henrich W, Greco BA, Steffes M, Tobe S, Shapiro JI, Jamerson K, Lyass A, Pencina K, Massaro JM, D'Agostino RB Sr, Cutlip DE, Murphy TP, Cooper CJ.

Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1180-8. doi: 10.2215/CJN.10491015. Epub 2016 May 25.

5.

Renal Artery Stent Outcomes: Effect of Baseline Blood Pressure, Stenosis Severity, and Translesion Pressure Gradient.

Murphy TP, Cooper CJ, Matsumoto AH, Cutlip DE, Pencina KM, Jamerson K, Tuttle KR, Shapiro JI, D'Agostino R, Massaro J, Henrich W, Dworkin LD.

J Am Coll Cardiol. 2015 Dec 8;66(22):2487-94. doi: 10.1016/j.jacc.2015.09.073.

6.

Renal artery stenosis and mean platelet volume.

Sayın MR, Yavuz N, Karabağ T, Çetiner MA, Öz İİ, Güngördük OA, Aydın M.

Anatol J Cardiol. 2016 Mar;16(3):197-201. doi: 10.5152/AnatolJCardiol.2015.6102. Epub 2015 Jun 18.

7.

Update on intervention versus medical therapy for atherosclerotic renal artery stenosis.

Mousa AY, AbuRahma AF, Bozzay J, Broce M, Bates M.

J Vasc Surg. 2015 Jun;61(6):1613-23. doi: 10.1016/j.jvs.2014.09.072. Review.

8.

Emergent unilateral renal artery stenting for treatment of flash pulmonary edema: fact or fiction?

Khan AA, McFadden EP.

Case Rep Cardiol. 2015;2015:659306. doi: 10.1155/2015/659306. Epub 2015 Feb 22.

9.

Endovascular intervention in renovascular disease: a pictorial review.

Khinda J, Athreya S.

Insights Imaging. 2014 Dec;5(6):667-76. doi: 10.1007/s13244-014-0363-z. Epub 2014 Oct 12.

10.

Transcatheter therapies for resistant hypertension: Clinical review.

Lokhandwala A, Dhoble A.

World J Cardiol. 2014 Aug 26;6(8):706-12. doi: 10.4330/wjc.v6.i8.706. Review.

11.

Use of renin-angiotensin system blockade in patients with renal artery stenosis.

Cohen JB, Townsend RR.

Clin J Am Soc Nephrol. 2014 Jul;9(7):1149-52. doi: 10.2215/CJN.04240414. Epub 2014 Jun 5. No abstract available.

12.

Management of atherosclerotic renovascular disease after Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL).

Herrmann SM, Saad A, Textor SC.

Nephrol Dial Transplant. 2015 Mar;30(3):366-75. doi: 10.1093/ndt/gfu067. Epub 2014 Apr 9. Review.

13.

Revascularization as a treatment to improve renal function.

Alderson HV, Ritchie JP, Kalra PA.

Int J Nephrol Renovasc Dis. 2014 Feb 20;7:89-99. doi: 10.2147/IJNRD.S35633. eCollection 2014. Review.

14.

Predictive role of renal resistive index for clinical outcome after revascularization in hypertensive patients with atherosclerotic renal artery stenosis: a monocentric observational study.

Bruno RM, Daghini E, Versari D, Sgrò M, Sanna M, Venturini L, Romanini C, Di Paco I, Sudano I, Cioni R, Lerman LO, Ghiadoni L, Taddei S, Pinto S.

Cardiovasc Ultrasound. 2014 Feb 20;12:9. doi: 10.1186/1476-7120-12-9.

15.

Roll-in experience from the Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study.

Murphy TP, Cooper CJ, Cutlip DE, Matsumoto A, Jamerson K, Rundback J, Rosenfield KA, Henrich W, Shapiro J, Massaro J, Yen CH, Burtch H, Thum C, Reid D, Dworkin L.

J Vasc Interv Radiol. 2014 Apr;25(4):511-20. doi: 10.1016/j.jvir.2013.09.018. Epub 2013 Dec 8.

16.

Cell-Based Therapies as an Adjunct to Revascularization in Experimental Atherosclerotic Reno Vascular Disease.

Eirin A, Ebrahimi B, Lerman LO.

J Clin Exp Cardiolog. 2012 Jul 3;3(8). pii: 1000e108. No abstract available.

17.

Stenting and medical therapy for atherosclerotic renal-artery stenosis.

Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen DJ, Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR, Shapiro JI, Rundback JH, Massaro JM, D'Agostino RB Sr, Dworkin LD; CORAL Investigators.

N Engl J Med. 2014 Jan 2;370(1):13-22. doi: 10.1056/NEJMoa1310753. Epub 2013 Nov 18.

18.

Darkness at the end of the tunnel: poststenotic kidney injury.

Eirin A, Lerman LO.

Physiology (Bethesda). 2013 Jul;28(4):245-53. doi: 10.1152/physiol.00010.2013. Review.

19.

The rise and fall of renal artery angioplasty and stenting in the United States, 1988-2009.

Liang P, Hurks R, Bensley RP, Hamdan A, Wyers M, Chaikof E, Schermerhorn ML.

J Vasc Surg. 2013 Nov;58(5):1331-8.e1. doi: 10.1016/j.jvs.2013.04.041. Epub 2013 Jun 28.

20.

RX Herculink Elite(®) renal stent system: a review of its use for the treatment of renal artery stenosis.

Colyer WR Jr.

Med Devices (Auckl). 2012;5:67-73. doi: 10.2147/MDER.S25150. Epub 2012 Aug 1.

Supplemental Content

Support Center